Drug Shortage Report for ATIVAN
Report ID | 210709 |
Drug Identification Number | 02041413 |
Brand name | ATIVAN |
Common or Proper name | Ativan 0.5mg |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LORAZEPAM |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500's |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-06 |
Estimated end date | 2024-06-14 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-26 |
Company comments | Sublingual presentation 0.5mg remain fully available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-03-26 | French | Compare |
v8 | 2024-03-26 | English | Compare |
v7 | 2024-02-09 | French | Compare |
v6 | 2024-02-09 | English | Compare |
v5 | 2024-01-30 | French | Compare |
v4 | 2023-12-04 | French | Compare |
v3 | 2023-12-04 | English | Compare |
v2 | 2023-11-17 | French | Compare |
v1 | 2023-11-17 | English | Compare |
Showing 1 to 9 of 9